A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.
Lastminute talks lean innovation strategy, plans Tripbod integration after email trial
11 April 2013
Tripbod, founded by UCL Alumna, Sally Broom, are entering a new deal with lastminutecom, after a successful trial period.
When you’re lastminute.com and others have been stealing your thunder in the same-day/late-deals market what do you do?
Find ways to differentiate your product/brand and add value of course. Easier said than done.
Lastminute’s head of innovation William Beckler says one of his own success metrics is to count the number of times he tries new things and they fail.
“If I’m not failing enough, then I’m not doing risky projects that are covering new things.”
However, a recent trial with experience marketplace Tripbod seems to have gone off well enough for Sabre-owned lastminute to be now seeking full integration into its offering.